No Access

THE CHALLENGES OF MEDICAL RESOURCE LIMITATIONS FOR TUBERCULOSIS UNDER THE COVID-19 PANDEMIC: A MATHEMATICAL MODELING OF CO-INFECTION AND OPTIMAL CONTROL

QIANXI DING

https://orcid.org/0009-0002-6631-5235

College of Science, Northeastern University, Shenyang 110819, Liaoning, P. R. China

Search for more papers by this author

and

NING LI

https://orcid.org/0000-0003-2236-0034

College of Science, Northeastern University, Shenyang 110819, Liaoning, P. R. China

E-mail Address: lining80@163.com

Corresponding author.

Search for more papers by this author

https://doi.org/10.1142/S0218339024500335Cited by:0 (Source: Crossref)

Abstract

Currently, more than 600 million people worldwide are diagnosed with COVID-19, while the implication of Tuberculosis cannot be ignored. The combination of COVID-19 and Tuberculosis exacerbates the catastrophe, dealing a serious blow to the healthcare system. This paper addresses how to develop effective and reasonable programs to combat the spread of COVID-19 and Tuberculosis in the absence of Tuberculosis medical resources, as well as exploring the impact of medical resources on optimal control implementation. Therefore, a co-infection dynamic of COVID-19 and Tuberculosis is constructed and analyzed. In order to investigate approaches to mitigate the disease transmission, a comprehensive and integrated study including sensitivity analysis, optimal control design and cost-effectiveness analysis is then performed. The simulation results illustrate that, the combination of the three control measures effectively achieves a win-win result in economic and epidemiological terms. In addition, the impact of Tuberculosis medical resources is highlighted, and the study shows that an appropriate increase in the medical resource supply for Tuberculosis during optimal control can have a stronger inhibitory effect on co-infection. Finally, based on the actual data, the model is validated by fitting the cumulative confirmed case curves of the two diseases.

Keywords:

References

1. Youngmee J , WHO international health regulations emergency committee for the COVID-19, Epidemiol Health 42 :e2020013, 2020. Crossref, Google Scholar
2. Tahir AM, Qiblawey Y, Khandakar A, Rahman T, Khurshid U, Musharavati F, Islam MT, Kiranyaz S, Al-Maadeed S, Chowdhury ME , Deep learning for reliable classification of COVID-19, MERS, and SARS from chest X-ray images, Cognit Comput 14 :1–21, 2022. Crossref, Web of Science, Google Scholar
3. Johns Hopkins University, Coronavirus Resource Center, 2023. Available from: https://coronavirus.jhu.edu/map.html. jhu.edu/map.html. Google Scholar
4. Florida R, Rodrí-guez-Pose A, Storper M , Cities in a post-COVID world, Urban Stud 2021, https://doi.org/10.1177/00420980211018072. Web of Science, Google Scholar
5. Dean AS, Auguet OT, Glaziou P, Zignol M, Ismail N, Kasaeva T, Floyd K , 25 years of surveillance of drug-resistant tuberculosis: Achievements, challenges, and way forward, Lancet Infect Dis 2022. Crossref, Web of Science, Google Scholar
6. Ahmed N, Hasnain SE , Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach, Tuberculosis (Edinb) 91(5) :407–413, 2011. Crossref, Web of Science, Google Scholar
7. Kuddus MA, Meehan MT, White LJ, McBryde ES, Adekunle AI , Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh, PLoS One 15(7) :e0236112, 2020. Crossref, Web of Science, Google Scholar
8. Bhunu CP , Mathematical analysis of a three-strain tuberculosis transmission model, Appl Math Model 35(9) :4647–4660, 2011. Crossref, Web of Science, Google Scholar
9. Trajman A, Felker I, Alves LC, Coutinho I, Osman M, Meehan SA, Singh UB, Schwartz Y , The COVID-19 and TB syndemic: The way forward, Int J Tuberc Lung Dis 26(8) :710–719, 2022. Crossref, Web of Science, Google Scholar
10. Visca D, Ong CW, Tiberi S, Centis R, Dambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G , Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects, Pulmonology 27(2) :151–165, 2021. Crossref, Web of Science, Google Scholar
11. Sy KT, Haw NJ, Uy J , Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19, Infect Dis 52(12) :902–907, 2020. Crossref, Web of Science, Google Scholar
12. Liebenberg D, Gordhan BG, Kana BD , Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management, Front Cell Infect Microbiol 12: 2022. Crossref, Web of Science, Google Scholar
13. Pai M, Kasaeva T, Swaminathan S , COVID-19’s devastating effect on tuberculosis care — a path to recovery, N Engl J Med 386(16) :1490–1493, 2022. Crossref, Web of Science, Google Scholar
14. Islam M , Extensively drug-resistant tuberculosis in the time of COVID-19 — How has the landscape changed for Pakistan? Disaster Med Public Health Prep 14(4) :e9–e10, 2020. Crossref, Google Scholar
15. Buonsenso D, Iodice F, Biala JS, Goletti D , COVID-19 effects on tuberculosis care in Sierra Leone, Pulmonology 27(1) :67, 2021. Crossref, Web of Science, Google Scholar
16. Teklu SW, Rao KP , HIV/AIDS-pneumonia codynamics model analysis with vaccination and treatment, Comput Math Methods Med 2022, 2022. Crossref, Web of Science, Google Scholar
17. Zhang J, Liu L, Li Y, Wang Y , An optimal control problem for dengue transmission model with Wolbachia and vaccination, Commun Nonlinear Sci 116 :106856, 2023. Crossref, Web of Science, Google Scholar
18. Berhe HW, Makinde OD, Theuri DM , Co-dynamics of measles and dysentery diarrhea diseases with optimal control and cost-effectiveness analysis, Appl Math Comput 347 :903–921, 2019. Web of Science, Google Scholar
19. Cui T, Liu P , Fractional transmission analysis of two strains of influenza dynamics, Results Phys 40 :105843, 2022. Crossref, Web of Science, Google Scholar
20. Okuonghae D, Aihie VU , Optimal control measures for tuberculosis mathematical models including immigration and isolation of infective, J Biol Syst 18(01) :17–54, 2010. Link, Google Scholar
21. Deng Y, Zhao Y , Mathematical modeling for COVID-19 with focus on intervention strategies and cost-effectiveness analysis, Nonlinear Dyn 110(4) 1–27, 2022, 3893–3919. Crossref, Web of Science, Google Scholar
22. Mame A, Sene N, Nometa I, Nwakanma CI, Nwafor EU, Iheonu NO, Okuonghae D , Analysis of COVID-19 and comorbidity co-infection model with optimal control, Optim Control Appl Methods 42(6) :1568–1590, 2021. Crossref, Google Scholar
23. Yuan Y, Li N , Optimal control and cost-effectiveness analysis for a COVID-19 model with individual protection awareness, Phys A: Stat Mech Appl 603 :127804, 2022. Crossref, Web of Science, Google Scholar
24. Asamoah JK, Jin Z, Sun GQ, Seidu B, Yankson E, Abidemi A, Oduro FT, Moore SE, Okyere E , Sensitivity assessment and optimal economic evaluation of a new COVID-19 compartmental epidemic model with control interventions, Chaos Solitons Fractals 146 :110885, 2021. Crossref, Web of Science, Google Scholar
25. Azar AT, Hassanien AE , Modeling, Control and Drug Development for COVID-19 Outbreak Prevention, Springer International Publishing AG, 2022. Crossref, Google Scholar
26. Nag S, Chakrabarty SP , Modeling the dynamics of COVID-19 transmission in India: Social distancing, regional spread and healthcare capacity, J Biol Syst 30(03) :647–672, 2022. Link, Web of Science, Google Scholar
27. Hezam IM, Foul A, Alrasheedi A , A dynamic optimal control model for COVID-19 and cholera co-infection in Yemen, Adv Differ Equ 2021(1) :1–30, 2021. Crossref, Web of Science, Google Scholar
28. Omame A, Abbas M, Onyenegecha CP , A fractional order model for the co-interaction of COVID-19 and Hepatitis B virus, Results Phys 37 :105498, 2022. Crossref, Web of Science, Google Scholar
29. Tchoumi SY, Diagne ML, Rwezaura H, Tchuenche JM , Malaria and COVID-19 co-dynamics: A mathematical model and optimal control, Appl Math Model 99 :294–327, 2021. Crossref, Web of Science, Google Scholar
30. Omame A, Abbas M, Onyenegecha CP , Backward bifurcation and optimal control in a co-infection model for SARS-CoV-2 and ZIKV, Results Phys 37 :105481, 2022. Crossref, Web of Science, Google Scholar
31. Omame A, Isah ME, Abbas M, Abdel-Aty AH, Onyenegecha CP , A fractional order model for dual variants of COVID-19 and HIV co-infection via Atangana–Baleanu derivative, Alex Eng J 61(12) :9715–9731, 2022. Crossref, Web of Science, Google Scholar
32. Ojo MM, Benson TO, Peter OJ, Goufo EF , Nonlinear optimal control strategies for a mathematical model of COVID-19 and influenza co-infection, Phys A: Stat Mech Appl 607 :128173, 2022. Crossref, Web of Science, Google Scholar
33. Ojo MM, Peter OJ, Goufo EF, Nisar KS , A mathematical model for the co-dynamics of COVID-19 and tuberculosis, Math Comput Simul 207 2023, 4989–520. Crossref, Web of Science, Google Scholar
34. Rwezaura H, Diagne ML, Omame A, de Espindola AL, Tchuenche JM , Mathematical modeling and optimal control of SARS-CoV-2 and tuberculosis co-infection: A case study of Indonesia, Model Earth Syst Environ 8 :5493–5520, 2022. Crossref, Web of Science, Google Scholar
35. Mekonen KG, Obsu LL , Mathematical modeling and analysis for the co-infection of COVID-19 and tuberculosis, Heliyon 8(4) :e11195, 2022. Crossref, Google Scholar
36. Mekonen KG, Balcha SF, Obsu LL, Hassen A , Mathematical modeling and analysis of TB and COVID-19 coinfection, J Appl Math 2022(10) :1–20, 2022. Crossref, Google Scholar
37. Marimuthu Y, Nagappa B, Sharma N, Basu S, Chopra KK , COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India, Indian J Tuberc 67(2) :177–181, 2020. Crossref, Google Scholar
38. Omame A, Abbas M, Onyenegecha CP , A fractional-order model for COVID-19 and tuberculosis co-infection using Atangana–Baleanu derivative, Chaos Solitons Fractals 153 :111486, 2021. Crossref, Web of Science, Google Scholar
39. Bandekar SR, Ghosh M , A co-infection model on TB-COVID-19 with optimal control and sensitivity analysis, Math Comput Simul 200 :1–31, 2022. Crossref, Web of Science, Google Scholar
40. Srivastava A, Srivastava PK , Nonlinear dynamics of a SIRI model incorporating the impact of information and saturated treatment with optimal control, Eur Phys J Plus 137(9) :1–25, 2022. Crossref, Web of Science, Google Scholar
41. Upadhyay RK, Pal AK, Kumari S, Roy P , Dynamics of an SEIR epidemic model with nonlinear incidence and treatment rates, Nonlinear Dyn 96(4) :2351–2368, 2019. Crossref, Web of Science, Google Scholar
42. National Health Commission of the People’s Republic of China, Seventh National Population Census Bulletin, 2021. Available from: https://www.gov.cn/guoqing/2021-05/13/content_5606149.htm. Google Scholar
43. Otoo D, Osman S, Poku SA, Donkoh EK , Dynamics of tuberculosis (tb) with drug resistance to first-line treatment and leaky vaccination: A deterministic modelling perspective, Comput Math Methods Med 2021 :5593864, 2021. Crossref, Web of Science, Google Scholar
44. Han Y, Jiang M, Xia D, He L, Lv X, Liao X, Meng J , COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster, Clin Immunol 214 :108413, 2020. Crossref, Web of Science, Google Scholar
45. Kar TK, Nandi SK, Jana S, Mandal M , Stability and bifurcation analysis of an epidemic model with the effect of media, Chaos Solitons Fractals 120 :188–199, 2019. Crossref, Web of Science, Google Scholar
46. Hethcote HW , The mathematics of infectious diseases, SIAM Rev 42(4) :599–653, 2000. Crossref, Web of Science, Google Scholar
47. Van den Driessche P, Watmough J , Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math Biosci 180(1–2) :29–48, 2002. Crossref, Web of Science, Google Scholar
48. Zhou K, Doyle JC , Essentials of Robust Control, Prentice Hall, Upper Saddle River, 1998. Google Scholar
49. Pan J, Chen Z, He Y, Liu T, Cheng X, Xiao J, Feng H , Why controlling the asymptomatic infection is important: A modelling study with stability and sensitivity analysis, Fractal Fract 6(4) :197, 2022. Crossref, Web of Science, Google Scholar
50. LaSalle J , Some extensions of Liapunov’s second method, IRE Trans Circuit Theory 7(4) :520–527, 1960. Crossref, Google Scholar
51. Castillo-Chavez C, Song B , Dynamical models of tuberculosis and their applications, Math Biosci Eng 1(2) :361, 2004. Crossref, Web of Science, Google Scholar
52. Health Commission of Hubei Province, COVID-19 Epidemic Situation in Hubei Province, 2022. Available from: http://wjw.hubei.gov.cn/bmdt/dtyw/202203/t20220321_4049340.shtml. Health Commission of Hubei Province, http://wjw.hubei.gov.cn/bmdt/dtyw/202203/ t20220321_4049340.shtml. Google Scholar
53. Atif M, Mukhtar S, Sarwar S, Naseem M, Malik I, Mushtaq A , Drug resistance patterns, treatment outcomes and factors affecting unfavourable treatment outcomes among extensively drug resistant tuberculosis patients in Pakistan; a multicentre record review, Saudi Pharm J 30(4) :462–469, 2022. Crossref, Web of Science, Google Scholar
54. Chowell G , Fitting dynamic models to epidemic outbreaks with quantified uncertainty: A primer for parameter uncertainty, identifiability, and forecasts, Infect Dis Model 2(3) :379–398, 2017. Google Scholar
55. Chowell G, Ammon CE, Hengartner NW, Hyman JM , Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions, J Theor Biol 241(2) :193–204, 2006. Crossref, Web of Science, Google Scholar
56. Chitnis N, Hyman JM, Cushing JM , Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model, Bull Math Biol 70(5) :1272–1296, 2008. Crossref, Web of Science, Google Scholar
57. Marino S, Hogue IB, Ray CJ, Kirschner DE , A methodology for performing global uncertainty and sensitivity analysis in systems biology, J Theor Biol 254(1) :178–196, 2008. Crossref, Web of Science, Google Scholar
58. Samsuzzoha MD, Singh M, Lucy D , Uncertainty and sensitivity analysis of the basic reproduction number of a vaccinated epidemic model of influenza, Appl Math Model 37(3) :903–915, 2013. Crossref, Web of Science, Google Scholar
59. Kirk DE , Optimal Control Theory: An Introduction, Courier Corporation, 2004. Google Scholar
60. Lenhart S, Workman JT , Optimal Control Applied to Biological Models, CRC Press, 2007. Crossref, Google Scholar
61. Cantor SB, Ganiats TG , Incremental cost-effectiveness analysis: The optimal strategy depends on the strategy set, J Clin Epidemiol 52(6) :517–522, 1999. Crossref, Web of Science, Google Scholar
62. Asamoah JK, Okyere E, Abidemi A, Moore SE, Sun GQ, Jin Z , Optimal control and comprehensive cost-effectiveness analysis for COVID-19, Results Phys 33 :105177, 2022. Crossref, Web of Science, Google Scholar
63. National Bureau of Statistics (NBS) of China, 2024. Available from: https://www.stats.gov.cn/sj/. Google Scholar
64. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa, Clin Infect Dis 73(7) :e2005–e2015, 2021. Crossref, Web of Science, Google Scholar
65. Agusto FB, Leite MC , Optimal control and cost-effective analysis of the 2017 meningitis outbreak in Nigeria, Infect Dis Model 4 :161–187, 2019. Crossref, Google Scholar
66. Awasthi AK, Singh PK , Tuberculosis management in India during COVID-19 crisis, J Public Health Policy 42(1) :185–189, 2021. Crossref, Web of Science, Google Scholar